We are live on ! Find out more
IGMS

IGM Biosciences
IGMS

Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

81 hedge funds and large institutions have $1.02B invested in IGM Biosciences in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

317% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 6

245% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 11

38% more capital invested

Capital invested by funds: $742M → $1.02B (+$281M)

31% more funds holding

Funds holding: 62 → 81 (+19)

2.89% more ownership

Funds ownership: 55% → 57.9% (+2.9%)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
81
Holders Change
+19
Holders Change %
+30.65%
% of All Funds
1.66%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
25
Increased
38
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Alkeon Capital Management
Alkeon Capital Management
New York
+$16.4M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
+$14.8M
3
State Street
State Street
Massachusetts
+$13.3M
4
CS
Candriam SCA
Luxembourg
+$8.28M
5
BlackRock
BlackRock
New York
+$6.61M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$33.5M
2
CAM
Cormorant Asset Management
Massachusetts
-$5.22M
3
LGM
Logos Global Management
California
-$4.98M
4
VC
Vivo Capital
California
-$4.87M
5
PHS
PFM Health Sciences
California
-$2.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$3.92M +$1.98M +32,617 +155%
Millennium Management
27
Millennium Management
New York
$3.39M +$2.27M +37,283 +407%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.61M +$1.04M +17,082 +91%
RJA
29
Raymond James & Associates
Florida
$2.29M – – –
TD Asset Management
30
TD Asset Management
Ontario, Canada
$1.82M +$79K +1,300 +6%
Citadel Advisors
31
Citadel Advisors
Florida
$1.67M +$115K +1,891 +9%
VIA
32
Vident Investment Advisory
Georgia
$1.61M +$1.34M +22,000 New
MAP
33
Moody Aldrich Partners
Massachusetts
$1.38M +$1.15M +18,873 New
Fidelity Investments
34
Fidelity Investments
Massachusetts
$1.37M +$358K +5,889 +46%
MPAM
35
Monarch Partners Asset Management
Massachusetts
$1.31M +$1.09M +17,884 New
SG Americas Securities
36
SG Americas Securities
New York
$1.24M +$916K +15,082 +802%
Squarepoint
37
Squarepoint
New York
$1.2M +$1,000K +16,457 New
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.18M +$978K +16,100 New
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$1.15M -$646K -10,637 -40%
Allianz Asset Management
40
Allianz Asset Management
Germany
$1.07M +$887K +14,608 New
CS
41
Credit Suisse
Switzerland
$985K +$819K +13,488 New
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$825K +$219K +3,600 +47%
AllianceBernstein
43
AllianceBernstein
Tennessee
$803K +$164K +2,700 +33%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$781K +$193K +3,174 +42%
Wells Fargo
45
Wells Fargo
California
$776K -$334K -5,503 -34%
Renaissance Technologies
46
Renaissance Technologies
New York
$694K +$577K +9,500 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$643K +$236K +3,881 +79%
AR
48
Advisory Research
Illinois
$584K -$3.04K -50 -0.6%
Morgan Stanley
49
Morgan Stanley
New York
$559K +$225K +3,703 +94%
AC
50
Athanor Capital
New York
$542K +$451K +7,429 New
1
2
3 4

IGMS Hedge Fund Activity: Q2 2020 in Review

81 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in IGM Biosciences (IGMS) for Q2 2020, worth a combined $1.02B — up 38% from $742M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new IGMS positions and 6 closed out — a net gain of 19 holders — while 38 added to existing stakes and 11 trimmed.

The largest buyer was Alkeon Capital Management, adding an estimated $16.4M. The largest seller was Janus Henderson Group, cutting an estimated $33.5M.

  • 81 institutional investors held IGM Biosciences (IGMS) as of Q2 2020, up from 62 in Q1 2020.
  • Funds reported $1.02B of IGM Biosciences stock for Q2 2020, up 38% quarter-over-quarter.
  • 25 funds opened new IGM Biosciences positions in Q2 2020 and 6 closed out, a net change of +19 holders.
  • The largest IGM Biosciences buyer in Q2 2020 was Alkeon Capital Management, an estimated $16.4M added.
  • The largest IGM Biosciences seller in Q2 2020 was Janus Henderson Group, an estimated $33.5M sold.

Based on aggregated 13F filings for Q2 2020.